Lancet (London, England)

Lancet · ISSN (e) 1474-547X · 95 papers in corpus
rct
doi:10.1016/S0140-6736(22)01475-1 ·PMID:36116480

BACKGROUND: Uterine fibroids are common non-cancerous neoplasm that cause heavy menstrual bleeding and other signs. Linzagolix is an oral gonadotropin-releasing hormone receptor antagonist taken once per day that dose-dependently suppresses…

other
doi:10.1016/S0140-6736(26)00404-6 ·PMID:41794423
letter 2025
doi:10.1016/s0140-6736(24)02511-x ·PMID:39892903
2025
doi:10.1016/s0140-6736(25)01917-8 ·PMID:41092928

BackgroundTimely and comprehensive analyses of causes of death stratified by age, sex, and location are essential for shaping effective health policies aimed at reducing global mortality. The Global Burden of Diseases, Injuries, and Risk Fa…

2025
doi:10.1016/s0140-6736(25)00055-8 ·PMID:40179933
other 2024
doi:10.1016/S0140-6736(24)02179-2 ·PMID:39368831
rct 2022
doi:10.1016/s0140-6736(22)00622-5 ·PMID:35717987

BACKGROUND: Endometriosis is a common cause of pelvic pain in women, for which current treatment options are suboptimal. Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, combined with estradiol and a progestin, was eva…

letter 2022
doi:10.1016/s0140-6736(22)00663-8 ·PMID:35717973
review 2021
doi:10.1016/S0140-6736(21)00389-5 ·PMID:33640070

Endometriosis is a common disease affecting 5-10% of women of reproductive age globally. However, despite its prevalence, diagnosis is typically delayed by years, misdiagnosis is common, and delivery of effective therapy is prolonged. Ident…

article 2020
doi:10.1016/s0140-6736(20)31693-7 ·PMID:32979978

BACKGROUND: Chronic pelvic pain affects 2-24% of women worldwide and evidence for medical treatments is scarce. Gabapentin is effective in treating some chronic pain conditions. We aimed to measure the efficacy and safety of gabapentin in w…

case-report 2019
doi:10.1016/S0140-6736(19)32094-X ·PMID:31526738
2018
doi:10.1016/s0140-6736(18)31694-5 ·PMID:30340847

BackgroundUnderstanding potential trajectories in health and drivers of health is crucial to guiding long-term investments and policy implementation. Past work on forecasting has provided an incomplete landscape of future health scenarios, …

2018
doi:10.1016/s0140-6736(18)32203-7 ·PMID:30496103

BackgroundGlobal development goals increasingly rely on country-specific estimates for benchmarking a nation's progress. To meet this need, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 estimated global, regiona…

2018
doi:10.1016/s0140-6736(18)32335-3 ·PMID:30415748

BackgroundHow long one lives, how many years of life are spent in good and poor health, and how the population's state of health and leading causes of disability change over time all have implications for policy, planning, and provision of …

2018
doi:10.1016/s0140-6736(18)32279-7 ·PMID:30496104

BackgroundThe Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2017) includes a comprehensive assessment of incidence, prevalence, and years lived with disability (YLDs) for 354 causes in 195 countries and territories f…

2018
doi:10.1016/s0140-6736(18)31202-9 ·PMID:29893223

BackgroundFemoroacetabular impingement syndrome is an important cause of hip pain in young adults. It can be treated by arthroscopic hip surgery, including reshaping the hip, or with physiotherapist-led conservative care. We aimed to compar…

2017
doi:10.1016/s0140-6736(17)32152-9 ·PMID:28919116

BackgroundMonitoring levels and trends in premature mortality is crucial to understanding how societies can address prominent sources of early death. The Global Burden of Disease 2016 Study (GBD 2016) provides a comprehensive assessment of …

2017
doi:10.1016/s0140-6736(17)32130-x ·PMID:28919118

BackgroundMeasurement of changes in health across locations is useful to compare and contrast changing epidemiological patterns against health system performance and identify specific needs for resource allocation in research, policy develo…

2017
doi:10.1016/s0140-6736(17)32154-2 ·PMID:28919117

BackgroundAs mortality rates decline, life expectancy increases, and populations age, non-fatal outcomes of diseases and injuries are becoming a larger component of the global burden of disease. The Global Burden of Diseases, Injuries, and …

letter 2017
doi:10.1016/s0140-6736(17)33049-0 ·PMID:29208299
letter 2017
doi:10.1016/s0140-6736(17)31344-2 ·PMID:28528751
2016
doi:10.1016/s0140-6736(16)31460-x ·PMID:27733283

BackgroundHealthy life expectancy (HALE) and disability-adjusted life-years (DALYs) provide summary measures of health across geographies and time that can inform assessments of epidemiological patterns and health system performance, help t…

2016
doi:10.1016/s0140-6736(16)31678-6 ·PMID:27733282

BackgroundNon-fatal outcomes of disease and injury increasingly detract from the ability of the world's population to live in full health, a trend largely attributable to an epidemiological transition in many countries from causes affecting…

2016
doi:10.1016/s0140-6736(16)31012-1 ·PMID:27733281

BackgroundImproving survival and extending the longevity of life for all populations requires timely, robust evidence on local mortality levels and trends. The Global Burden of Disease 2015 Study (GBD 2015) provides a comprehensive assessme…

2015
doi:10.1016/s0140-6736(14)60649-8 ·PMID:25616312

Acute pancreatitis, an inflammatory disorder of the pancreas, is the leading cause of admission to hospital for gastrointestinal disorders in the USA and many other countries. Gallstones and alcohol misuse are long-established risk factors,…